首页> 美国卫生研究院文献>Elsevier Public Health Emergency Collection >Characterisation of canine parvovirus strains isolated from cats with feline panleukopenia
【2h】

Characterisation of canine parvovirus strains isolated from cats with feline panleukopenia

机译:从猫泛白细胞减少症猫中分离出的犬细小病毒株的表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Unlike the original canine parvovirus type 2 (CPV-2), CPV-2 variants have gained the ability to replicate in vivo in cats but there is limited information on the disease patterns induced by these variants in the feline host. During 2008, two distinct cases of parvoviral infection were diagnosed in our laboratories. A CPV-2a variant was identified in a 3-month-old Persian kitten displaying clinical sign of feline panleukopenia (FPL) (acute gastroenteritis and marked leukopenia) and oral ulcerations, that died eight days after the onset of the disease. Two pups living in the same pet shop as the cat were found to shed a CPV-2a strain genetically identical to the feline virus and were likely the source of infection. Also, non-fatal infection by a CPV-2c strain occurred in a 2.5-month-old European shorthair kitten displaying non-haemorrhagic diarrhoea and normal white blood cell counts. By sequence analysis of the major capsid protein (VP2) gene, the feline CPV-2c strain showed 100% identity to a recent canine type-2c isolate. Both kittens had been administered multivalent vaccines against common feline pathogens including FPL virus. Whether and to which extent the FPL vaccines can protect cats adequately from the antigenic variants of CPV-2 should be assessed.
机译:与原始的2型犬细小病毒(CPV-2)不同,CPV-2变体已获得在猫体内体内复制的能力,但在猫宿主中由这些变体诱导的疾病模式的信息有限。在2008年期间,我们的实验室诊断出两例细小病毒感染病例。在一只3个月大的波斯小猫中发现了CPV-2a变体,该小猫表现出猫泛白细胞减少症(FPL)(急性胃肠炎和明显的白细胞减少症)和口腔溃疡的临床体征,该疾病发作八天后死亡。发现与该猫住在同一宠物店的两只幼犬脱落了CPV-2a毒株,该毒株在遗传上与猫病毒相同,并且很可能是感染源。同样,在2.5个月大的欧洲短毛猫小猫中,CPV-2c株发生了非致命性感染,显示出非出血性腹泻和白细胞计数正常。通过主要衣壳蛋白(VP2)基因的序列分析,猫CPV-2c株与最近的犬2c型分离株显示100%的同一性。两只小猫都已接种了针对常见猫病原体(包括FPL病毒)的多价疫苗。应该评估FPL疫苗是否以及在何种程度上可以充分保护猫免受CPV-2抗原变体的侵害。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号